Welcome to LookChem.com Sign In|Join Free
  • or
methyl (S)-3-(pyrrolidin-2-yl)propanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

689303-75-1

Post Buying Request

689303-75-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

689303-75-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 689303-75-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,9,3,0 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 689303-75:
(8*6)+(7*8)+(6*9)+(5*3)+(4*0)+(3*3)+(2*7)+(1*5)=201
201 % 10 = 1
So 689303-75-1 is a valid CAS Registry Number.

689303-75-1Relevant academic research and scientific papers

Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor Microenvironment

Jackson, Jeffrey J.,Ketcham, John M.,Younai, Ashkaan,Abraham, Betty,Biannic, Berenger,Beck, Hilary P.,Bui, Minna H. T.,Chian, David,Cutler, Gene,Diokno, Raymond,Hu, Dennis X.,Jacobson, Scott,Karbarz, Emily,Kassner, Paul D.,Marshall, Lisa,McKinnell, Jenny,Meleza, Cesar,Okal, Abood,Pookot, Deepa,Reilly, Maureen K.,Robles, Omar,Shunatona, Hunter P.,Talay, Oezcan,Walker, James R.,Wadsworth, Angela,Wustrow, David J.,Zibinsky, Mikhail

, p. 6190 - 6213 (2019/08/02)

Recruitment of suppressive CD4+ FOXP3+ regulatory T cells (Treg) to the tumor microenvironment (TME) has the potential to weaken the antitumor response in patients receiving treatment with immuno-oncology (IO) agents. Human Treg express CCR4 and can be recruited to the TME through the CC chemokine ligands CCL17 and CCL22. In some cancers, Treg accumulation correlates with poor patient prognosis. Preclinical data suggests that preventing the recruitment of Treg and increasing the population of activated effector T cells (Teff) in the TME can potentiate antitumor immune responses. We developed a novel series of potent, orally bioavailable small molecule antagonists of CCR4. From this series, several compounds exhibited high potency in distinct functional assays in addition to good in vitro and in vivo ADME properties. The design, synthesis, and SAR of this series and confirmation of its in vivo activity are reported.

New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids

Fuelep, Guenther H.,Hoesl, Cornelia E.,Hoefner, Georg,Wanner, Klaus T.

, p. 809 - 824 (2007/10/03)

We synthesized proline and pyrrolidine-2-alkanoic acid derivatives in their enantiomerically pure form and evaluated them for their affinity to the GABA transport proteins GAT-1 and GAT-3. Among the compounds presented herein, (R)-pyrrolidine-2-acetic aci

Asymmetric Baylis-Hillman reactions: Catalysis using a chiral pyrrolizidine base

Barrett, Anthony G. M.,Cook, Andrew S.,Kamimura, Akio

, p. 2533 - 2534 (2007/10/03)

A novel chiral pyrrolizidine base 5 derived from L-proline promotes the Baylis-Hillman reaction of ethyl and methyl vinyl ketones with electron deficient aromatic aldehydes with moderate levels of enantiomeric excess.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 689303-75-1